Press releases

Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military

Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test

Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial

Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team 

Inflammatix Presents Data at ACEP24 Showing High Diagnostic and Prognostic Accuracy of its TriVerity™ Test Regardless of Patient Immune Status 

Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis

Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System

Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System